Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
13,625.00    95.00 (0.70%)
Bid:
13,580.00
Ask:
13,590.00
Spread: 10.00 (0.074%)
Market Cap: £15.55b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Trading Statement

30 Oct 2024 07:00

RNS Number : 1232K
Next PLC
30 October 2024
 

Trading Statement - 30 October 2024

HEADLINES

·

Full price1 sales in the third quarter (August - October) were up +7.6% versus last year. This was +2.6% ahead of our guidance for the quarter of +5.0%.

·

We believe the strong performance was driven by the early arrival of colder weather this year, versus an unusually warm September and early October last year.

·

We are increasing guidance for Q4 full price sales growth by +1.0%, to +3.5% (see analysis below).

·

The improved sales in Q3 along with our forecast for Q4 add £43m to full price sales and £10m to profit; accordingly we are upgrading our profit2 guidance for the full year from £995m to £1,005m.

1 Full price sales include all items sold in NEXT Retail, NEXT Online including third-party brands, and NEXT Finance interest income, but excludes Sale events, Clearance, Total Platform commission and subsidiaries' sales. 

2 NEXT Group profit before tax excludes: (1) the cost of brand amortisation, (2) the profit attributable to shares that we do not own in subsidiary companies, and (3) an exceptional, non-cash, loss relating to the closure of our defined benefit pension scheme.

FULL PRICE SALES PERFORMANCE

Full price sales performance by business division is set out below. Variances to last year are shown for the third quarter and the year to date.

Full price sales by division versus last year

Q3: 13 weeks

to 26 October

Year to

26 October

Online NEXT UK

+7.8%

+4.2%

Online LABEL UK

+8.0%

+6.0%

Total Online UK

+7.9%

+4.9%

Retail

+2.9%

- 0.8%

Total UK

+5.8%

+2.4%

Online Overseas

+20.4%

+22.0%

Total Product full price sales

+8.1%

+5.6%

NEXT Finance interest income

+0.0%

+3.2%

Total full price sales

+7.6%

+5.5%

 

Q4 FULL PRICE SALES GUIDANCE

The chart below shows our full price sales performance against last year (blue bar) and against two years ago (dotted line). As shown, our Q4 forecast against last year looks pessimistic, but is much more realistic when compared with two years ago. We are more confident in the two year comparison as we believe the overperformance in Q3 this year is likely to have pulled forward sales from Q4.

GUIDANCE FOR FULL YEAR SALES, PROFIT AND EARNINGS PER SHARE

Our revised guidance for sales, profit and Earnings Per Share for the full year is summarised below. For completeness, our previous guidance is shown in grey.

New guidance

Previous guidance

Guidance for the full year 2024/25

Full year

£ (e)

% Versus

2023/24

Full year

£ (e)

% Versus

2023/24

Full price sales

£5.02bn

+4.9%

£4.98bn

+4.0%

Total Group sales3

(inc. markdown, subsidiaries and investments)

£6.27bn

+7.4%

£6.23bn

+6.6%

NEXT Group profit before tax

£1,005m

+9.5%

£995m

+8.4%

Pre-tax EPS

839.3p

+10.8%

830.4p

+9.7%

Post-tax EPS

632.4p

+9.3%

625.7p

+8.1%

3. Total Group sales are the sum of total sales (full price and markdown) from all of the Group's divisions plus revenue from subsidiary companies. Subsidiaries' turnover is calculated using our share of our subsidiaries' turnover. For example, we own 74% of Joules so we include 74% of their sales in our top line.

Total Group sales for the full year are expected to be up +7.4% on last year, which is +2.5% higher than our expected growth in full price sales of +4.9%. The difference is the result of acquisitions completed during the last year. We acquired 97% of FatFace in October 2023 and increased our equity share in Reiss in September 2023 and June 2024; we now have a 74% shareholding in Reiss.

CHRISTMAS TRADING STATEMENT

We are scheduled to give an update on sales to Saturday 28 December, on Tuesday 7 January 2025.

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

 

 

 

Date:

Embargoed until 07:00 hrs, Wednesday 30 October 2024

Contacts:

Jonathan Blanchard, Chief Financial Officer (analyst calls)

 

NEXT PLC

Tel: 0333 777 8888

 

Alistair Mackinnon-Musson

Email: next@rowbellpr.com

 

Rowbell PR

Tel: 020 7717 5239

Photographs:

https://www.nextplc.co.uk/media/image-gallery/campaign-images

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVKLFLZBLLFBF
Date   Source Headline
16th Jan 20267:00 amRNSRedemption of B Shares
15th Jan 20266:20 pmRNSIssue of B Shares
15th Jan 202611:48 amRNSResult of Meeting
9th Jan 20267:00 amRNSDirectorate Change
6th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSCircular and Notice of General Meeting
19th Dec 20257:00 amRNSCircular and Notice of General Meeting
1st Dec 202512:58 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSSale of land at Waltham Abbey
14th Nov 20254:05 pmRNSAGM Update
3rd Nov 20257:00 amRNSTotal Voting Rights
30th Oct 202510:29 amRNSDirector/PDMR Shareholding
29th Oct 20257:00 amRNSTrading Statement
17th Oct 20253:36 pmRNSDirector/PDMR Shareholding
6th Oct 20255:04 pmRNSHolding(s) in Company
3rd Oct 20254:45 pmRNSDirector/PDMR Shareholding
1st Oct 20252:40 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20254:27 pmRNSDirector/PDMR Shareholding
19th Sep 20255:06 pmRNSTransaction in Own Shares
19th Sep 202510:47 amRNSDirector/PDMR Shareholding
18th Sep 20255:26 pmRNSTransaction in Own Shares
18th Sep 20257:00 amRNSResults for the Half Year Ended July 2025
15th Sep 20259:31 amRNSHolding(s) in Company
3rd Sep 20255:20 pmRNSTransaction in Own Shares
2nd Sep 20255:38 pmRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTotal Voting Rights
18th Aug 20255:25 pmRNSNon-discretionary Share Repurchase Programme
18th Aug 20255:20 pmRNSTransaction in Own Shares
15th Aug 20255:11 pmRNSTransaction in Own Shares
14th Aug 20255:21 pmRNSTransaction in Own Shares
13th Aug 20255:43 pmRNSTransaction in Own Shares
12th Aug 20255:24 pmRNSTransaction in Own Shares
11th Aug 20255:19 pmRNSTransaction in Own Shares
4th Aug 20259:52 amRNSResult of Audit Tender
1st Aug 20258:34 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSTrading Statement
18th Jul 20252:17 pmRNSUpdate on Outstanding Notes and RCF
16th Jul 202512:37 pmRNSFinal Results of Tender Offer
16th Jul 20258:47 amRNSIndicative Results of Tender Offer
7th Jul 20258:42 amRNSTender Offer
1st Jul 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTotal Voting Rights
15th May 20253:38 pmRNSResult of AGM
9th May 20252:58 pmRNSDirector/PDMR Shareholding
8th May 20257:00 amRNSTrading Statement
1st May 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.